NIH-funded research R01 grant

How calcium channel problems contribute to autism and developmental delays

Official title: Dissecting the Role of Ca2+ Channel Dysfunction in the Pathogenesis of Neurodevelopmental Disorders

Funded at University of Maryland Baltimore · NIH-11321279 · Data updated 2026-11-12

This project links changes in brain calcium channels to autism and related developmental conditions to understand how altered calcium signaling affects nerve cell communication.

More Neurodevelopmental Disorders research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startApril 14, 2025
Project endJanuary 31, 2030
Funding year2026
Award (this year)$680,243
NIH project number5R01MH137160-02
Project IDNIH-11321279 on NIH RePORTER

Who could benefit from this research

Could help

People with autism or developmental delay who have known or suspected mutations in calcium channel genes, or families willing to provide genetic samples, would be most relevant to this work.

Less likely to help

Patients without calcium channel gene changes or those seeking immediate clinical treatments are unlikely to see direct benefit from this basic science-focused project.

What this research studies

This work looks at how changes in calcium channels in brain cells may lead to autism and other developmental delays. The team uses genetic information and laboratory models, including CRISPR-edited cells and animal models, to recreate specific gene changes linked to risk. They measure channel activity, neuron electrical signaling, and downstream effects on brain cell function. The goal is to connect particular mutations (like those seen in Timothy syndrome) to how neurons behave and to identify molecular steps that could be targeted later.

Why it matters

Potential benefit: If successful, the research could reveal specific molecular causes of some forms of autism and point to targets for future treatments or diagnostics.

How similar studies have gone: Previous studies have linked CaV1.2 channel mutations (for example in Timothy syndrome) to neurodevelopmental problems, but turning those findings into clinical treatments remains largely unproven.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Dick, Ivy E — University of Maryland Baltimore
  • Study coordinator: Dick, Ivy E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.